The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.
Conclusion: Metformin is associated with lower level of CA 19-9 in type 2 diabetes mellitus patients. It may have a protective role in preventing pancreatic damage and pancreatic cancer in diabetic individuals. CA 19-9 level could be an effective indicator of glycemic control, disease progression and lipid metabolism in patients with type 2 diabetes mellitus.
PMID: 30341867 [PubMed - in process]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carbohydrates | Carcinoma | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | General Medicine | India Health | Insulin | Metformin | Pancreas | Pancreatic Cancer | Study